AbbVie Showcases Innovative Pipeline Across Five Key Therapeutic Areas at the 6th China International Import Expo

"Chasing the Light with Love, Illuminating Life"

ShanghaiOctober 30, 2023 /PR Newswire/ --The 6th China International Import Expo is about to open, with the world's top revenue rankings5AbbVie Inc., a research-based biopharmaceutical company, partners with its subsidiary Allergan Aesthetics toThree participations in the CIIE, leveraging the "grand stage" of high-level opening-up that is the CIIE,Bringing multiple innovative products covering five key therapeutic areas: immunology, oncology, ophthalmology, neuroscience, and aesthetics.Among them, innovative products in the field of immunologyJAKInhibitor RuiFu^®And the innovative blood cancer drug, Venclexta^®As beneficiaries of the spillover effects of the CIIE, they will showcase their exploration achievements in more disease areas, looking forward to the swift approval and market launch of additional new indications in China. Ophthalmic drug Ozurdex^®will also showcase two major indications at the CIIE.Heavyweight Product in the Field of ImmunologySKYRIZI and EPKINLY in the field of hematological tumors will make their China debut at the CIIE. Additionally, at the CIIE this"On a large platform where 'exhibits' turn into 'products' and 'products' transform into an 'ecosystem',"At this year's CIIE, we will also join hands with multiple partners, including the government, enterprises, academic institutions, and associations, to jointly build, develop, and share a healthcare innovation ecosystem. Together, we will explore better solutions to crack disease challenges and fulfill our long-term commitment of being "patient-centered."

"Life Time and Space" - AbbVie's Innovative Drug Exhibition Area at the 6th CIIE

The AbbVie Innovative Medicine Exhibition Area at this year's CIIE will be themed "Chasing Light with AbbVie "Light Up Life" as the exhibition theme, and"Life Spacetime"Showcasing AbbVie's blockbuster innovations and diversified collaborations as the main concept, in this extraordinary and imaginative space-time, AbbVie works hand in hand with global partners to "chase the light of life," exploring groundbreaking therapies day and night to solve various complex medical challenges. The innovative products born from this remarkable space-time are showcased at the CIIE.“Acceleration”Landing in China, bringing hope to Chinese patients from“Visible”The innovative drug to“Can be used”Innovative drugs also signify the continuation of AbbVie's connection with the CIIE. "The Space-Time of Life" is the continuation and elevation of the concepts from AbbVie’s previous two participations in the CIIE — "Extraordinary Lab" and "Future Star Cluster," reflecting AbbVie's characteristics as a world-leading R&D-based biopharmaceutical company — innovation, leadership, and win-win cooperation.

AbbVie Vice President and General Manager of China, Dong Lijun, stated: "Through the window of the CIIE, AbbVie has witnessed China's opening-up doors widening further, transforming China’s vast market into a significant opportunity for AbbVie. AbbVie has also seen its innovative drugs move from "concept" to "medicine box" and finally onto the "medical insurance reimbursement list," as well as the growth in the number of AbbVie employees in China from...The growth miracle from 400 to more than 2,200 people. After a decade of deep cultivation in China, we have now entered the AbbVie China 2.0 era. AbbVie will actively embrace opportunities in China, using the CIIE as the starting point to showcase China's speed and wisdom. While accelerating the introduction of global innovative products into China, we will also bring China's solutions for diverse collaborations in innovative drugs to the world.。Looking ahead to the next decade, AbbVie plans to leverage the strong spillover effects of the CIIE to2030As of the year, it was launched in China30innovative drugs, and through open and diversified cooperation with all sectors, empower the high-quality development of China's pharmaceuticals and healthcare industry, contributing to the realization of 'Healthy China.'2030'Full Speed Ahead Towards the Goal.”